Stratos Wealth Partners, Ltd. Verastem, Inc. Transaction History

Stratos Wealth Partners, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$2.57 - $4.85 $61,679 - $116,399	-24,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$1.15 - $2.4 $16,099 - $33,600	14,000 Added 140.0%	24,000 $51,000
Q3 2019 Nov 12, 2019	BUY	$1.21 - $1.59 $12,100 - $15,900	10,000 New	10,000 $12,000
Q3 2019 Nov 12, 2019	SELL	$1.21 - $1.59 $12,100 - $15,900	-10,000 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$2.79 - $4.09 $27,900 - $40,900	10,000 New	10,000 $30,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.29B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.